Published in Cytotechnology on June 23, 2006
Cell therapies for liver diseases. Liver Transpl (2012) 1.24
Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix. J Clin Exp Hepatol (2014) 0.84
Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells (2015) 0.80
Future of bioartificial liver support. World J Gastrointest Surg (2009) 0.79
Liver regeneration. Science (1997) 12.80
Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol (2004) 6.36
Cre recombinase: the universal reagent for genome tailoring. Genesis (2000) 6.29
Acute liver failure. N Engl J Med (1993) 3.81
Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog (1991) 3.21
Transcription factors in liver development, differentiation, and regeneration. Hepatology (2003) 3.06
Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J (1989) 2.89
Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc Natl Acad Sci U S A (1988) 2.30
Cell encapsulation: promise and progress. Nat Med (2003) 2.18
Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos (2003) 2.01
Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet (1988) 1.82
Liver regeneration. J Am Coll Surg (2003) 1.79
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol (1988) 1.76
Cytokines in the liver. Eur J Gastroenterol Hepatol (2001) 1.72
Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation (2003) 1.70
Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res (1990) 1.66
Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA (2003) 1.62
Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology (1996) 1.57
Technology of mammalian cell encapsulation. Adv Drug Deliv Rev (2000) 1.57
Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J Cell Biol (1992) 1.53
Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol (2003) 1.51
Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Transplantation (1999) 1.51
Maintenance of differentiated rat hepatocytes in primary culture. Proc Natl Acad Sci U S A (1985) 1.40
Clinical extracorporeal hybrid liver support--phase I study with primary porcine liver cells. Xenotransplantation (2003) 1.35
Histological organization in hepatocyte organoid cultures. Am J Pathol (2001) 1.31
Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol Bioeng (2004) 1.30
Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology (1992) 1.26
Xenotransplantation: infectious risk revisited. Am J Transplant (2004) 1.25
Clinical application of bioartificial liver support systems. Ann Surg (2004) 1.24
Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs (1999) 1.21
Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol (2003) 1.20
Recent developments on human cell lines for the bioartificial liver. Int J Artif Organs (2002) 1.18
The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch A Pathol Anat Histopathol (1993) 1.12
Pig endogenous retroviruses and xenotransplantation. Xenotransplantation (2002) 1.11
In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol (1997) 1.11
Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol Bioeng (2000) 1.08
Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation (2003) 1.08
Role of shear stress and immune responses in liver regeneration after a partial hepatectomy. Surg Today (1999) 1.06
Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development (2003) 1.06
Effects of extracellular matrix on hepatocyte growth and gene expression: implications for hepatic regeneration and the repair of liver injury. Semin Liver Dis (1990) 1.05
Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs (1993) 1.04
Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation (1999) 1.04
Cell biology and pathology of liver sinusoidal endothelial cells. Med Electron Microsc (2004) 1.03
A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol Prog (1992) 1.03
A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog (2000) 1.02
Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem Biophys Res Commun (2000) 1.02
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl (2001) 1.01
Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide (2001) 0.99
History, challenges and perspectives of cell microencapsulation. Trends Biotechnol (2004) 0.99
Primary human liver cells as source for modular extracorporeal liver support--a preliminary report. Int J Artif Organs (2002) 0.99
Application of spheroid culture to human hepatocytes and maintenance of their differentiation. Biol Cell (1994) 0.98
Large-scale preparation and function of porcine hepatocyte spheroids. Int J Artif Organs (1996) 0.97
Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials (1997) 0.97
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology (1997) 0.95
Novel strategies for immortalization of human hepatocytes. Artif Organs (2001) 0.95
Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. Transplantation (2002) 0.94
Microstructured scaffolds for liver tissue cultures of high cell density: morphological and biochemical characterization of tissue aggregates. J Cell Biochem (2005) 0.93
Sinusoidal endothelial cells of the liver: fine structure and function in relation to age. J Electron Microsc Tech (1990) 0.93
TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology (2005) 0.93
Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. Transplantation (1997) 0.92
Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure. Blood Purif (2005) 0.92
Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int J Artif Organs (2002) 0.91
Evaluation of cell behaviour related to physico-chemical properties of polymeric membranes to be used in bioartificial organs. Biomaterials (2002) 0.91
Scavenger properties of cultivated pig liver endothelial cells. Comp Hepatol (2004) 0.91
A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation (1995) 0.91
Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients. ASAIO J (2001) 0.91
Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs (1999) 0.90
Development of a hybrid liver support system: a review. Int J Artif Organs (1996) 0.90
Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. J Surg Res (2003) 0.90
Clinical management of acute hepatic failure. Intensive Care Med (2001) 0.90
3-D coculture of hepatic sinusoidal cells with primary hepatocytes-design of an organotypical model. Exp Cell Res (1996) 0.89
Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device. Biotechnol Prog (2002) 0.89
Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Transplant Proc (2005) 0.87
Differentiation of putative hepatic stem cells derived from adult rats into mature hepatocytes in the presence of epidermal growth factor and hepatocyte growth factor. Differentiation (2003) 0.87
A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery (2004) 0.87
Crude liver membrane fractions and extracellular matrix components as substrata regulate differentially the preservation and inducibility of cytochrome P-450 isoenzymes in cultured rat hepatocytes. Eur J Biochem (1993) 0.87
In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol (2005) 0.87
Liver support therapy: an overview of the AMC-bioartificial liver research. Dig Surg (2005) 0.87
Molecular and cellular features of hepatic regeneration. J Surg Res (2004) 0.86
A new concept of bioartificial liver based on a fluidized bed bioreactor. Ther Apher (1999) 0.86
Survival and function of isolated hepatocytes after cryopreservation. Chem Biol Interact (1999) 0.85
Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int J Artif Organs (2004) 0.85
Development of a small-scale bioreactor for drug metabolism studies maintaining hepatospecific functions. Xenobiotica (1998) 0.85
Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels. Cytotechnology (1992) 0.84
Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J (1993) 0.84
Biologic liver support: optimal cell source and mass. Int J Artif Organs (2002) 0.84
Modeling O2 transport within engineered hepatic devices. Biotechnol Bioeng (2003) 0.84
Growth factors and nonparenchymal cell conditioned media induce mitogenic responses in stable long-term adult rat hepatocyte cultures. Exp Cell Res (2004) 0.84
Hybrid artificial liver support system for treatment of severe liver failure. World J Gastroenterol (2005) 0.84
Liver sinusoidal endothelial cell modulation upon resection and shear stress in vitro. Comp Hepatol (2004) 0.84
Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif Organs (1998) 0.84
Cryopreserved microencapsulated hepatocytes--transplantation studies in Gunn rats. Transplantation (1993) 0.83
Maintained function of primary human hepatocytes by cellular interactions in coculture: implications for liver support systems. Transpl Int (1998) 0.83
Thawed human hepatocytes in primary culture. Cryobiology (1992) 0.83
Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant (1994) 0.83
Cell-cell organization and functions of 'sinusoids' in liver microcirculation system. J Electron Microsc (Tokyo) (1999) 0.83
New capsule with tailored properties for the encapsulation of living cells. J Biomed Mater Res (1998) 0.82
Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell Transplant (1994) 0.82
The bioartificial liver: state-of-the-art. Eur J Surg Suppl (1998) 0.82
Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet (2012) 4.54
Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos (2003) 2.01
Repair of chronic osteochondral defects using predifferentiated mesenchymal stem cells in an ovine model. Am J Sports Med (2010) 1.81
Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter. Catheter Cardiovasc Interv (2013) 1.46
Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol (2008) 1.44
Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett (2006) 1.43
Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondrocytes. Eur Biophys J (2007) 1.25
Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg (2009) 1.06
New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev (2003) 1.04
Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system. Biomaterials (2007) 1.03
Matrix-associated implantation of predifferentiated mesenchymal stem cells versus articular chondrocytes: in vivo results of cartilage repair after 1 year. Am J Sports Med (2011) 0.99
Quantitative real-time polymerase chain reaction: methodical analysis and mathematical model. J Biomol Tech (2004) 0.99
Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs. Arthritis Res Ther (2010) 0.96
Development and characterization of a small-scale bioreactor based on a bioartificial hepatic culture model for predictive pharmacological in vitro screenings. Biotechnol Bioeng (2006) 0.93
Connected culture of murine hepatocytes and HUVEC in a multicompartmental bioreactor. Tissue Eng Part A (2009) 0.92
Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J Biochem Mol Toxicol (2003) 0.92
Analysis of stem cell lipids by offline HPTLC-MALDI-TOF MS. Anal Bioanal Chem (2008) 0.92
Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver Int (2009) 0.92
Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice. Cancer Res (2008) 0.91
Evaluation of cell behaviour related to physico-chemical properties of polymeric membranes to be used in bioartificial organs. Biomaterials (2002) 0.91
Development and validation of a novel bioreactor system for load- and perfusion-controlled tissue engineering of chondrocyte-constructs. Biotechnol Bioeng (2008) 0.90
Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device. Biotechnol Prog (2002) 0.89
Identification of human cells in brain xenografts and in neural co-cultures of rat by in situ hybridisation with Alu probe. J Neurosci Methods (2003) 0.89
Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization. Cardiovasc Res (2012) 0.88
RGD-dependent integrins are mechanotransducers in dynamically compressed tissue-engineered cartilage constructs. J Biomech (2009) 0.87
Functionalized self-assembling peptide hydrogel enhance maintenance of hepatocyte activity in vitro. J Cell Mol Med (2009) 0.87
A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery (2004) 0.87
Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor. Biomaterials (2006) 0.85
The concept of in vivo airway tissue engineering. Biomaterials (2012) 0.84
Thrombopoietin is a growth factor for rat hepatic progenitors. Eur J Gastroenterol Hepatol (2008) 0.84
Human hepatocyte functions in a crossed hollow fiber membrane bioreactor. Biomaterials (2009) 0.84
Determination of pore size distribution at the cell-hydrogel interface. J Nanobiotechnology (2011) 0.83
Determination of the decay rate constant for hepatocytes immobilized in alginate microcapsules. J Microencapsul (2010) 0.82
A simple non-destructive method for the fixation and immunostaining of cultured cells encapsulated in alginate. Biotechnol Appl Biochem (2006) 0.82
Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition. Drug Discov Today (2011) 0.82
Gel entrapment culture of rat hepatocytes for investigation of tetracycline-induced toxicity. Toxicol Appl Pharmacol (2009) 0.82
Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. J Neurosurg (2005) 0.82
Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opin Drug Metab Toxicol (2010) 0.82
Preclinical characterization of primary porcine hepatocytes in a clinically relevant flat membrane bioreactor. Biomaterials (2009) 0.81
Interspecies difference in liver-specific functions and biotransformation of testosterone of primary rat, porcine and human hepatocyte in an organotypical sandwich culture. Toxicol Lett (2009) 0.81
Three dimensional cultures of rat liver cells using a natural self-assembling nanoscaffold in a clinically relevant bioreactor for bioartificial liver construction. J Cell Physiol (2012) 0.81
The cardiovascular tissue-reactor: a novel device for the engineering of heart valves. Artif Organs (2006) 0.80
Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes. Toxicol Lett (2006) 0.80
Formation of three-dimensional fetal myocardial tissue cultures from rat for long-term cultivation. Dev Dyn (2006) 0.80
Vascular guidance: microstructural scaffold patterning for inductive neovascularization. Stem Cells Int (2010) 0.80
Timing and targeting of cell-based VEGF165 gene expression in ischemic tissue. J Surg Res (2008) 0.79
Biotransformation of diazepam in a clinically relevant flat membrane bioreactor model using primary porcine hepatocytes. Fundam Clin Pharmacol (2011) 0.79
Mesenchymal stem cells restore lung function by recruiting resident and nonresident proteins. Cell Transplant (2011) 0.79
Enrichment of human beta 1 bri/alpha 6 bri/CD71 dim keratinocytes after culture in defined media. Cells Tissues Organs (2008) 0.79
Purification and characterization of the thyrotropin-releasing hormone (TRH)-degrading serum enzyme and its identification as a product of liver origin. Eur J Biochem (2002) 0.79
A multi-center study on the regenerative effects of erythropoietin in burn and scalding injuries: study protocol for a randomized controlled trial. Trials (2013) 0.79
The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model. J Neurosurg (2005) 0.78
Recombinant human erythropoietin plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. Rejuvenation Res (2010) 0.78
Two compartment model of diazepam biotransformation in an organotypical culture of primary human hepatocytes. Toxicol Appl Pharmacol (2008) 0.78
Improved functions of human hepatocytes on NH3 plasma-grafted PEEK-WC-PU membranes. Biomaterials (2009) 0.77
Tuning liver stiffness against tumours: an in vitro study using entrapped cells in tumour-like microcapsules. J Mech Behav Biomed Mater (2012) 0.77
Nanostructured self-assembling peptides as a defined extracellular matrix for long-term functional maintenance of primary hepatocytes in a bioartificial liver modular device. Int J Nanomedicine (2013) 0.77
Bioreactor developments for tissue engineering applications by the example of the bioartificial liver. Adv Biochem Eng Biotechnol (2002) 0.77
Biodegradable and synthetic membranes for the expansion and functional differentiation of rat embryonic liver cells. Acta Biomater (2010) 0.76
Isolation and Characterization of CD271⁺ Stem Cells Derived from Sheep Dermal Skin. Cells Tissues Organs (2015) 0.76
Analysis of extracellular matrix production in artificial cartilage constructs by histology, immunocytochemistry, mass spectrometry, and NMR spectroscopy. J Nanosci Nanotechnol (2006) 0.76
Intracellular nucleotide pools and ratios as tools for monitoring dedifferentiation of primary porcine hepatocytes in culture. Cytotechnology (2006) 0.76
Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor. Mol Cell Biochem (2009) 0.76
Erythropoietin enhances cell proliferation and survival of human fetal neuronal progenitors in normoxia. Brain Res (2012) 0.76
Rat embryonic liver cell expansion and differentiation on NH3 plasma-grafted PEEK-WC-PU membranes. Biomaterials (2009) 0.76
Detection of nanolevel drug metabolites in an organotypic culture of primary human hepatocytes and porcine hepatocytes with special reference to a two-compartment model. Int J Nanomedicine (2012) 0.75
Devices for stem cell isolation and delivery: current need for drug discovery and cell therapy. Expert Rev Med Devices (2014) 0.75
Drug-coated balloons in peripheral arterial disease. EuroIntervention (2011) 0.75
Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. Basic Clin Pharmacol Toxicol (2004) 0.75
The influence of oxygen supply on metabolism of neural cells cultured on a gas-permeable PTFE foil. Biotechnol Prog (2010) 0.75
Cryopreservation of primary porcine liver cells in an organotypical sandwich model in a clinically relevant flat membrane bioreactor. Biotechnol Lett (2010) 0.75
Effect of native and NH3 plasma-functionalized polymeric membranes on the gene expression profiles of primary hepatocytes. J Tissue Eng Regen Med (2011) 0.75
Evaluation of liver support systems for preclinical testing by animal trials. Artif Organs (2006) 0.75